Risk of hepatitis B virus reactivation during therapies for hepatocellular carcinoma: a systematic reviewdoi:10.1002/hep.32241hepatitislocal ablationsurgical resectionsystemic chemo or immuno therapytransarterial chemoembolizationMargarita PapatheodoridiUCL Institute for Liver and Digestive Health Royal Free ...